• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us
You are here: Home / Featured / Jeremy Farrar, to take on chief scientist role at WHO

Jeremy Farrar, to take on chief scientist role at WHO

December 21, 2022 By Lalita Panicker Leave a Comment

Jeremy Farrar, Director of the Wellcome Trust. Credit: Wellcome Library, London. Wellcome Images

Jeremy Farrar, director of the Wellcome Trust, one of the largest nongovernmental science funders, will step down early next year to become the chief scientist at the World Health Organization (WHO). He will replace Soumya Swaminathan, the first person to hold the post. Swaminathan, a paediatrician, announced last month that she would be leaving to focus on public health in India. https://www.science.org/content/article/jeremy-farrar-leaves-top-job-wellcome-trust-become-chief-scientist-who?

During Farrar’s decade at the helm of Wellcome, the organization’s focus has broadened from basic biomedical science to global health concerns, including mental health, the health effects of climate change, and infectious diseases. During the devastating Ebola outbreak in West Africa in 2014–15, Wellcome funded a series of ground breaking vaccine and treatment trials. At the time, Farrar criticized WHO—and the rest of the world—for not acting fast enough to stem the outbreak.

Trained as a neurologist before focusing on infectious diseases for most of his career, Farrar will now lead the agency’s science division. “Jeremy will accelerate our efforts to ensure WHO, its Member States and our partners benefit from cutting-edge, life-saving science and innovations,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement. Swaminathan, who took the job 9 months before COVID-19 emerged, also spent considerable time as one of the public faces of WHO’s pandemic response.

Princeton University health economist Janet Currie says WHO has made an “excellent” choice. “Dr Farrar is a superb scientist who has experience in all of the relevant aspects of the job,” she writes in an email, “from managing a lab in the field to his leadership of the Wellcome Trust.” He also has the political skills, Currie says, “to navigate the competing interests of [WHO’s member states] in order to focus on what the science has to say.”

Farrar spent nearly 2 decades leading a University of Oxford research group, partly funded by Wellcome, at a hospital in Ho Chi Minh City, Vietnam. There, he and his colleagues studied dengue, tuberculosis, typhoid, and other tropical diseases. In 2004, the group also helped identify one of the first patients in an outbreak of H5N1 avian influenza in humans and then studied the clinical characteristics of the disease as well as the impact of oseltamivir, an antiviral drug.

During the COVID-19 pandemic, Farrar has been outspoken in his support for measures to reduce transmission of SARS-CoV-2. He served on the U.K. Scientific Advisory Group for Emergencies until late October 2021, frequently criticizing the government when it delayed responding to rising cases with more stringent rules.

“COVID will be with us forever. In this sense, the phrase ‘We will have to learn to live with it’ is true,” Farrar told Der Spiegel in a recent interview. At the same, “anything we can do to reduce the transmission is a good thing,” he said. “In the U.K., I’m one of the very few people now still wearing a mask on public transport.”

Filed Under: Featured, Featured Stories, International, News, Newsletter, Profiles Tagged With: Jeremy Farrar, Wellcome Trust, WHO

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Articles

  • Renewed fears of a bird flu pandemic; The latest health stories from around the world
  • More oversight needed for “gain of function” research says expert panel; The latest health stories from around the world
  • Marion Biotech to be investigated by Indian drug regulator
  • Sesame to be added to list of major food allergens
  • Approval of Alzheimer’s drug “rife with irregularities”

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2023 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.